Medilabo RFP has been awarded a ¥30 million subsidy from Kyoto Prefecture under the Kyoto Economic Gardening Support Enhancement Project. The program supports innovation in product and business development. The funding will be used for the development and manufacturing of Medilabo’s nasal formulation targeting neurodegenerative diseases. more information.